Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liang Fu
Observed name:
Fu, Liang
Institution:
Shenzhen Third People’s Hospital
Observed institutions:
Capital Medical University,
Southern University of Science and Technology,
Beijing Chest Hospital,
Shenzhen Third People’s Hospital
ORCID:
0000-0003-1112-8010
Observed ORCID:
0000-0003-1112-8010
OpenAlex ID:
A5080180799
Guidelines for treatment of drug-susceptible tuberculosis and patient care-2017 update
2018
·
Jingtao Gao
, Xiaochun Wang
, et al.
·
Chinese Journal of Asthma
·
235
Natural Progression of Childhood Asthma Symptoms and Strong Influence of Sex and Puberty
2014
·
Liang Fu
, Robert J. Freishtat
, et al.
·
Annals of the American Thoracic Society
·
117
WHO treatment guidelines for isoniazid-resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis
2018
·
Liang Fu
, Jingtao Gao
, et al.
·
Chinese Journal of Asthma
·
102
Insignificant difference in culture conversion between bedaquiline-containing and bedaquiline-free all-oral short regimens for multidrug-resistant tuberculosis
2021
·
Liang Fu
, Taoping Weng
, et al.
·
International Journal of Infectious Diseases
·
42
PDF
Allogeneic Vγ9Vδ2 T-Cell Therapy Promotes Pulmonary Lesion Repair: An Open-Label, Single-Arm Pilot Study in Patients With Multidrug-Resistant Tuberculosis
2021
·
Juan Liang
, Liang Fu
, et al.
·
Frontiers in Immunology
·
37
PDF
A cross-sectional study: a breathomics based pulmonary tuberculosis detection method
2023
·
Liang Fu
, Lei Wang
, et al.
·
BMC Infectious Diseases
·
34
PDF
Multicentre evaluation of Xpert MTB/RIF assay in detecting urinary tract tuberculosis with urine samples
2019
·
Yu Chen
, Peng Wu
, et al.
·
Scientific Reports
·
30
PDF
Selecting an appropriate all-oral short-course regimen for patients with multidrug-resistant or pre-extensive drug-resistant tuberculosis in China: A multicenter prospective cohort study
2023
·
Liang Fu
, Xilin Zhang
, et al.
·
International Journal of Infectious Diseases
·
18
PDF
Prospects of contezolid (MRX-I) against multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis
2022
·
Min Yang
, Senlin Zhan
, et al.
·
Drug Discoveries & Therapeutics
·
15
PDF
Breathomics for diagnosing tuberculosis in diabetes mellitus patients
2024
·
Rong Xu
, Ying Zhang
, et al.
·
Frontiers in Molecular Biosciences
·
12
Detecting latent tuberculosis infection with a breath test using mass spectrometer: A pilot cross-sectional study
2023
·
Liang Fu
, Yong Feng
, et al.
·
BioScience Trends
·
12
PDF
Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China
2022
·
Jin Zou
, Shuyan Chen
, et al.
·
Antimicrobial Agents and Chemotherapy
·
12
Deep Amplicon Sequencing Reveals Culture-dependent Clonal Selection of Mycobacterium tuberculosis in Clinical Samples
2024
·
Jiuxin Qu
, Wanfei Liu
, et al.
·
Genomics Proteomics & Bioinformatics
·
9
Evaluation of Sulfasalazine as an Adjunctive Therapy in Treating Pulmonary Pre-XDR-TB: Efficacy, Safety, and Treatment Implication
2024
·
Liang Fu
, Wenfei Wang
, et al.
·
Infection and Drug Resistance
·
5
PDF
Chinese expert consensus on the combined use of antiviral drugs for influenza
2025
·
Jing Yuan
, Haimei Zhang
, et al.
·
BioScience Trends
·
4
PDF
Tissue-wide profiling of human lungs reveals spatial sequestration of macrophages in tuberculosis
2025
·
Wei Xiao
, Andrew J. Sawyer
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
4
PDF
Case report: Significant relief of linezolid-induced peripheral neuropathy in a pre-XDR-TB case after acupuncture treatment
2022
·
Yuping Mo
, Zhu Zhu
, et al.
·
Frontiers in Neurology
·
4
PDF
Chinese expert consensus on the combined use of antiviral drugs for novel coronavirus infection
2025
·
Guangbin Chen
, Jing Yuan
, et al.
·
BioScience Trends
·
3
PDF
Acupuncture as adjunctive treatment for linezolid-induced peripheral neuropathy: a case series report
2024
·
Yuping Mo
, Fan Nie
, et al.
·
Frontiers in Neurology
·
3
PDF
Superior antiviral efficacy of combined 3CL protease and RdRp inhibition compared to 3CL protease inhibitor monotherapy in hospitalized COVID-19 patients
2025
·
Yuan Gao
, Jiaying Zhang
, et al.
·
Journal of Infection
·
2
PDF
Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR]
2023
·
Liang Fu
, Juan Xiong
, et al.
·
BMC Infectious Diseases
·
2
PDF
Faster, higher, stronger: the evolution of clinical perspectives on pan-TB
2024
·
Liang Fu
, Guofang Deng
, et al.
·
One Health & Implementation Research
·
1
PDF
[Influence of education level on self-evaluation and control of patients with bronchial asthma].
2008
·
Hai-jin Zhao
, Shao-xi Cai
, et al.
·
PubMed
·
1
Data Readiness of Inpatient Discharge Abstracts for Pulmonary Tuberculosis With Hemoptysis: A Retrospective Computable Phenotyping and Label Validation Study (Preprint)
2026
·
Lili Ye
, Xiandong Cao
, et al.
Population Pharmacokinetic Modeling of Pyrazinamide Among Chinese Patients With Drug-Sensitive or Multidrug-Resistant Tuberculosis
2024
·
Shuyan Chen
, Weiqiao Rao
, et al.
·
Therapeutic Drug Monitoring
Show more works
View as search
Works count:
33
Citation count:
704
H-index:
12
I10-index:
12
Year
Topic
Type